Prospective Randomized Study of Glutamin Protective Properties in Cardiac Surgery.
Phase of Trial: Phase III
Latest Information Update: 31 Oct 2013
At a glance
- Drugs Alanylglutamine (Primary)
- Indications Ischaemic heart disorders
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 27 Aug 2012 Planned End Date changed from 1 Sep 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 27 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.